Detection of Embryonic Trisomy 21 in the First Trimester Using Maternal Plasma Cell-Free RNA

Prenatal trisomy 21 (T21) screening commonly involves testing a maternal blood sample for fetal DNA aneuploidy. It is reliable but poses a cost barrier to universal screening. We hypothesized maternal plasma RNA screening might provide similar reliability but at a lower cost. Discovery experiments u...

Descripción completa

Detalles Bibliográficos
Autores principales: Weiner, Carl P., Weiss, Mark L., Zhou, Helen, Syngelaki, Argyro, Nicolaides, Kypros H., Dong, Yafeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221829/
https://www.ncbi.nlm.nih.gov/pubmed/35741220
http://dx.doi.org/10.3390/diagnostics12061410

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221829/
https://www.ncbi.nlm.nih.gov/pubmed/35741220
http://dx.doi.org/10.3390/diagnostics12061410

Ejemplares similares